vania-janet/multiturn-rag-retrieval-data huggingface dataset:
Guidance on “Long COVID” as a Disability Under the ADA, Section | HHS.gov
Put simply, they are entitled to full and equal opportunities to participate in and enjoy all aspects of civic and commercial life. 
For example, this may mean that businesses or state or local governments will sometimes need to make changes to the way that they operate to accommodate a person’s long COVID-related limitations.  For people whose long COVID qualifies as a disability, these changes, or “reasonable modifications,” may include:

Providing additional time on a test for a student who has difficulty concentrating
Modifying procedures so a customer who finds it too tiring to stand in line can announce their presence and sit down without losing their place in line
Providing refueling assistance at a gas station for a customer whose joint or muscle pain prevents them from pumping their own gas
Modifying a policy to allow a person who experience dizziness when standing to be accompanied by their service animal that is trained to stabilize them

5. What federal resources are there for people with symptoms of long COVID?

The Office for Civil Rights of the Department of Health and Human Services (HHS) has the following page on civil rights and COVID-19: https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/index.html.

	
If you believe that an entity covered by HHS civil rights laws has violated your rights protected under these authorities, you may file a complaint at https://www.hhs.gov/ocr/complaints/index.html. 

The Civil Rights Division of the Department of Justice has the following page on its ADA.gov website that discusses topics related to COVID-19 and the ADA:  https://www.ada.gov/emerg_prep.html.
	
If you believe that you or another person has been discriminated against by an entity covered by the ADA, you may file a complaint with the Disability Rights Section (DRS) in the Department of Justice.  Information about how to file a complaint is available at https://www.ada.gov/fact_on_complaint.htm.
Clinical Care Quick Reference for COVID-19 | CDC
Clinical Care Quick Reference for COVID-19 | CDC
 
 

 

Skip directly to site content
Skip directly to search

An official website of the United States government Here's how you know 

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

 

Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People

Ã

Submit

HOME
 COVID-19

 

 

Clinical Care Quick Reference for COVID-19Clinical Care Quick Reference for COVID-19 


	Updated May 22, 2024	

Print

Minus

Related Pages

This quick reference highlights key COVID-19 Clinical Care information for healthcare professionals and provides selected links to full guidance and research for easier CDC web navigation.

COVID-19 Vaccination: Clinical Resources

QUICK REFERENCECaring for Patients

Signs and symptoms of COVID-19 can include fever, chills, cough, shortness of breath, fatigue, muscle aches, headache, loss of taste or smell, sore throat, nasal congestion or rhinorrhea, vomiting or diarrhea, and skin rashes.
Some patients with COVID-19 may progress to dyspnea and severe disease about one week after symptom onset.
Clinicians who wish to consider the use of therapeutics, or other available investigational therapies, should review the Infectious Diseases Society of America (ISDA) Guidelines on the Treatment and Management of Patients with COVID-19 and the American College of Physicians Clinical Guidelines and Recommendations on COVID-19.

For patients who are at higher risk for severe illness from COVID-19, treatment is available.
MORE DETAILS

Clinical Care
ISDA Guidelines on the Treatment and Management of Patients with COVID-19
American College of Physicians Clinical Guidelines and Recommendations on COVID-19
Preventing the Spread of Respiratory Viruses When Sick

QUICK REFERENCEPeople at Increased Risk for Severe Illness

Older adults are at higher risk for severe illness from COVID-19.
About MHV - My HealtheVet - My HealtheVet
Get Involved
Subscribe

About

Contact us

What's new

	Sign in to Manage Your Health Care 
	

Sign in
Register

My HealtheVet

About MHV

About My HealtheVetAbout My HealtheVet offers you tips and tools to help you partner with your health care team, so together you may work to manage your health. Here you may find useful resources when you need them. The support tools on this page are designed to enrich your experience with My HealtheVet and help you make informed decisions.

 FAQsFind answers to frequently asked questions about My HealtheVet's online tools and features. Learn MoreLearn how to use your VA health record, or your self-reported information to partner with your health care team. How to Use MHVLearn how to use My HealtheVet and better manage your health care online. User GuidesStep-by-Step guides on how to use specific features offered. MetricsDiscover the usage metrics behind My HealtheVet. View how many Veterans are using Secure Messaging, downloading Blue Button reports, requesting prescription refills, and more.

 

	Back to top
	

Feedback

AboutSite OverviewSite MapHelp & User GuidesFAQPrivacy & SecurityTerms and ConditionsPoliciesPrivacy PolicyWeb PoliciesFOIAAccessibilitySystem UseImportant LinksVA HomeWhite HouseUSA.govInspector GeneralFacility and Service LocatorQuick LinksMobile AppsTriCareVA Dental InsuranceFind a VA FormSubscribe to Receive My HealtheVet Updates Your email address My HealtheVetFacebook Twitter YouTube My HealtheVet Help Desk:You can call Monday - Friday, 7:00 a.m. - 7:00 p.m. (Central Time)1-877-327-00221-800-877-8339 (TTY)Contact My HealtheVetfor any questions or concerns about this site. Veteran's Crisis Line: DIAL 988 then PRESS 1 

We're here anytime, day or night - 24/7

	If you are a Veteran in crisis or concerned about one, connect with our caring,
COVID-19 Vaccines At VA | Veterans Affairs
You have a bleeding disorder or are on a blood thinner
You have a condition that weakens your immune system and makes you immunocompromised (like cancer, HIV, an organ transplant, or a genetic immune deficiency)
You’re taking a medicine that affects your immune system (like chemotherapy or corticosteroids)
You’re pregnant, planning to become pregnant, or breastfeeding
You’ve received another COVID-19 vaccine

If you’ve had a severe allergic reaction to any ingredients in a COVID-19 vaccine, you shouldn’t get the same COVID-19 vaccine again. But you may be able to receive a different type of COVID-19 vaccine.
Go to the CDC website to learn more about COVID-19 vaccines and allergic reactions 

 Currently available COVID-19 vaccines 
 

The FDA has approved or authorized 3 updated 2023-2024 COVID-19 vaccines for public use:

The updated 2023-2024 Pfizer-BioNTech vaccine
The updated 2023-2024 Moderna vaccine
The updated 2023-2024 Novavax vaccine

Note: The Janssen (Johnson & Johnson) vaccine is no longer available in the U.S.

After you get your vaccine

 What to expect after you get a COVID-19 vaccine 
 

You may have some side effects after you get a COVID-19 vaccine. Side effects are normal signs that your body is building protection against COVID-19.
These side effects may feel like the flu. They may even affect your ability to work or do other daily activities. But any side effects should go away in a few days.
Some people have reported severe allergic reactions to a COVID-19 vaccine. When you get a COVID-19 vaccine at VA, we may closely monitor your reaction for either 15 or 30 minutes after your vaccine. We’ll also give you information about what to do if you experience any side effects.
Learn more about what to expect after a COVID-19 vaccine on the CDC website

 How we monitor vaccine safety 
 

Millions of people in the United States have now received COVID-19 vaccines under the most intense safety monitoring in U.S. history.
Covid-19 Vaccines


StaffMedia RepresentativeResearcher / StatisticianPerson Interested InInfant and Child HealthMen’s HealthSenior HealthWomen’s HealthYouth and Young Adult's HealthLGBT HealthProgramsCenter for Healthy CommunitiesCalifornia Tobacco ControlChildhood Lead Poisoning PreventionChronic Disease ControlChronic Disease Surveillance and ResearchEmergency PreparednessSee MoreCenter for Environmental HealthDivision of Food and Drug SafetyDivision of Radiation Safety and Environmental ManagementSee MoreCenter for Family HealthGenetic Disease Screening ProgramMaternal, Child, and Adolescent HealthWomen, Infants and ChildrenCenter for Health Care QualityHealthcare-Associated Infections ProgramLicensing and CertificationCenter for Health Statistics and InformaticsEnd of Life Option ActMedical Marijuana Identification Card ProgramVital RecordsVital Records Data and StatisticsCenter for Infectious DiseasesHIV/AIDSBinational Border HealthCommunicable Disease ControlCommunicable Disease Emergency ResponseRefugee HealthSee MoreDirector / State Public Health OfficerLegislative and Governmental AffairsLet's Talk CannabisOffice of Health EquityOffice of CommunicationsSee MoreCenter for Laboratory SciencesLaboratory Field ServicesOffice of State Public Health Laboratory DirectorSee MoreOther CDPH OfficesEmergency Preparedness OfficePrivacy OfficeOffice of RegulationsSee MoreA-Z Index

Covid19Vaccines

 
 

Top Menu

Division of Communicable Disease ControlCurrently selected
CAIR

Division of Communicable Disease Control > Pages > COVID-19 > Covid19Vaccines

HomeCovid 19COVID-19 VaccinesCovid-19 Vaccines

Left Menu
 

RecentCurrently selectedAbout the Viral and Rickettsial Disease LabCalREDIECalREDIE Contact UsCDER Information for Health ProfessionalsChlamydiaCommunicable Disease Emergency Response ProgramDCDC Contact UsDCDC Information for Local Health DepartmentsDCDC ResourcesGonorrheaHepatitis CInfectious Diseases BranchInterpreting Zika Virus Test ResultsPelvic Inflammatory Disease (PID)Sexually Transmitted Diseases Control BranchSyphilisTrichomoniasisVRDL Contact InformationVRDL Guidelines for Specimen Collection and Submission for Pathologic TestingVRDL Specimen Submittal Forms

COVID-19 Vaccines

Toggle navigation

COVID-19 Menu
Surveillance & Data Analytics
Private sector, non-governmental organizations and academia
Various other organizations are also supporting this critical effort by providing:

Google Community Mobility Reports
Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.


	Last Updated Mar. 26, 2021	Source: 	National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

Facebook
Twitter
LinkedIn
Syndicate

homeCOVID-19About COVID-19plus iconVariantsHow COVID-19 SpreadsReinfectionAnimals and COVID-19plus iconWildlifePetsToolkitHealth EquitySymptomsTestingMedical ConditionsPreventionplus iconMasksplus iconTypes of Masks and RespiratorsUse and Care of MasksHow to Use Your N95 RespiratorVentilationplus iconHome VentilationImproving Ventilation In BuildingsFacility Cleaning & Ventilationplus iconUpper-Room Ultraviolet Germicidal IrradiationVentilation in BuildingsSchool Ventilation ToolVaccinesplus iconStay Up to Date with VaccinesOverview of COVID-19 VaccinesHow COVID-19 Vaccines WorkYour Vaccinationplus iconWhen Getting Your VaccineSpecific Groups of PeopleSafety of COVID-19 Vaccinesplus iconAllergic ReactionsVaccine Safety in Children & TeensMyocarditis and PericarditisInvestigating MyocarditisReported Adverse EventsCOVID-19 Vaccine Effectivenessplus iconVaccine Effectiveness StudiesAbout COVID-19 Vaccinesplus iconFrequently Asked QuestionsBenefits of Getting VaccinatedMyths & FactsTreatments & MedicationsLong COVIDplus iconCaring for People with Long COVIDPatient Appointment TipsData & Surveillanceplus iconHospitalization Surveillance Network COVID-NETplus iconCOVID-NET DashboardCOVID-NET
Guidance on “Long COVID” as a Disability Under the ADA, Section | HHS.gov
28 C.F.R. §§ 35.108(b), 36.105(b); 45 C.F.R. 92.102(c). back to note 11
 12. While this guidance document focuses on long COVID, we note that COVID-19 is also a physiological condition affecting one or more body systems, and is therefore also a physical or mental impairment. back to note 12

 Content created by Office for Civil Rights (OCR) Content last reviewed July 26, 2021

Back to top

Contact HHS

Careers

HHS FAQs

Nondiscrimination Notice

HHS Archive

Accessibility Statement

Privacy Policy

Viewers & Players

Budget/Performance

Inspector General

Web Site Disclaimers

EEO/No Fear Act

FOIA

The White House

USA.gov

Vulnerability Disclosure Policy

Sign Up for Email Updates
Receive the latest updates from the Secretary, Blogs, and News Releases.
Sign Up

 HHS Headquarters
 

200 Independence Avenue, S.W.
 Washington, D.C. 20201
 Toll Free Call Center: 1-877-696-6775​
COVID-19 | محکمہ صحت
ہمارے ڈیٹا پیجز میں کیس کی شرح، ہسپتال میں داخل ہونا، اموات، ویکسینیشن، مختلف حالتیں اور بہت کچھ شامل ہے۔

COVID-19 ڈیٹا

 COVID-19

رسائی

بیماریوں کے کنٹرول اور روک تھام کے مراکز

محکمہ صحت

ڈس کلیمر

اس ویب سائٹ پر استعمال شدہ فائل فارمیٹس

زبان کی مدد

رازداری کی پالیسی

سائٹ کا نقشہ

ہم سے رجوع فرمائیں
FACEBOOKPINTERESTTWITTERYOUTUBE

 آپ کا براؤزر iFrames کو سپورٹ نہیں کرتا ہے۔
 

ترجمے کی خدمات
یہ صفحہ دوسری زبانوں میں دستیاب ہے۔

ترجمہ کریں۔

English

Español

中文

繁體中文

Русский

יידיש

বাংলা

한국어

Kreyòl Ayisyen

Italiano

العربية

Polski

Français

اردو
About COVID-19 Vaccines | Veterans Affairs
We’ve used this type of vaccine in the U.S for more than 30 years. 
The Novavax COVID-19 vaccine injects the coronavirus spike protein itself into the body to induce an immune response. In contrast, mRNA COVID-19 vaccines (Pfizer, Moderna) teach our body how to make the spike protein to induce an immune response.

 mRNA COVID-19 vaccines don’t change your DNA 
 

mRNA vaccines that protect you from COVID-19 don’t alter your DNA. These vaccines work outside of your cell’s nucleus (where your DNA is kept). The vaccines teach your cells how to make a protein that triggers an immune response. Your cells then break down the mRNA and get rid of it soon after they’ve finished using the instructions.

 COVID-19 vaccines can’t give you COVID-19 
 

The current COVID-19 vaccines, and the vaccines still in development, use one of these methods:

An inactivated virus
A harmless piece of the virus
A gene from the virus

None of these can cause COVID-19.
Learn more about how COVID-19 vaccines work on the CDC website

 Vaccines protect you, your family, and your community 
 

How vaccines protect you
Vaccines help train your body’s natural immune system to recognize and fight a specific disease by stimulating a response to the virus that causes that disease.
When a virus is introduced to your body for the first time, your immune system mounts a defense. This includes making antibodies that help kill or neutralize the virus. If you’re exposed to the same virus again, these antibodies also help your immune system recognize and fight the virus quickly.
Learn more about how COVID-19 vaccines work on the CDC website
How vaccines protect the people around you
Protecting whole communities from diseases like COVID-19 is an important reason for everyone to get vaccines. We call this “community immunity.”
When enough people are vaccinated and develop immunity to a certain virus, that virus can’t spread as easily from person to person. This means that everyone in the community is less likely to get infected.
COVID-19 Overview and Infection Prevention and Control Priorities in non-U.S. Healthcare Settings | CDC
Revised COVID-19 Preventative actions section to reflect vaccination, masks, and additional preventative actions that should be continued
Added additional references to preventative actions section
Removed treatment section
Added information on IPC in the context of vaccination delivery
Revised list of Aerosol Generating Procedures based on updated guidance from WHO and updated references

On This Page

COVID-19 BackgroundEmergenceTransmissionSymptomsPeople at Higher Risk 

Prevention and TreatmentWhat is IPC?ResourcesReferences 

Training SlidesCOVID-19 Overview and Infection Prevention and Control Priorities in non-US Healthcare Settings [PPT – 5 MB]
Top of PagePurpose and Scope of this documentThis overview was created for healthcare workers in non-U.S. healthcare settings and government officials at ministries of health working on the Coronavirus Disease 2019 (COVID-19) response.
The information in this document draws from the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) guidance documents and Infection Prevention and Control (IPC) priorities for the response to COVID-19 in healthcare settings and includes information that can be used in non-U.S. contexts.
Structure of the document
This overview is organized by first presenting a background on coronaviruses. It then briefly describes the emergence, transmission, symptoms, prevention, and treatment of COVID-19. The rest of the document reviews COVID-19 IPC priorities, in non-U.S. healthcare settings.
Top of PageCoronavirus Background:
Coronaviruses are a large family of viruses that can cause illness in animals or humans. In humans there are several known coronaviruses that cause respiratory infections. These coronaviruses range from the common cold to more severe diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19.
Top of PageCoronavirus Disease 2019:
Emergence
COVID-19 was identified in Wuhan, China in December 2019.
Interim Guidelines for Biosafety and COVID-19 | CDC
Overview and MethodsCOVID-19 Data SourcesForecastingplus iconHospital ForecastsVariant Surveillanceplus iconGenomic SurveillanceTracking VariantsHealthcare Workersplus iconClinical Careplus iconQuick ReferenceClinical Care ConsiderationsOutpatient Treatment OverviewUnderlying Medical ConditionsChildrenPost-COVID Conditions: Healthcare ProvidersPost-COVID Conditions: CDC ScienceTestingplus iconTesting OverviewAntibody TestingInfection Control Guidanceplus iconPostmortem GuidancePotential Exposure at WorkPandemic Planning ScenariosCOVID-19SurgeStaff ShortagesElectronic Case ReportingTrainingNon-US Healthcare Settingsplus iconCOVID-19 & IPC OverviewTriaging Sick PatientsOutpatient FacilitiesAdditional Tools and ResourcesLab Professionalsplus iconTestingplus iconAntigen Testing GuidelinesNucleic Acid Amplification TestsPoint-of-Care & Rapid TestingOther Diagnostic TestsFlu SARS-CoV-2 Multiplex AssayReporting Lab Dataplus iconReporting SARS-CoV-2 Sequencing ResultsBiosafety for Specimen HandlingSpecimen CollectionHealth Departmentsplus iconSurveillance & Data Analyticsplus iconReporting COVID-19 CasesElectronic Case ReportingCOVIDTracer & COVIDTracer AdvancedSprayers Safety PrecautionsCommunication Resourcesplus iconPrint ResourcesVideosPeople with Intellectual & Developmental Disabilitiesplus iconResources for People with IDDEasy to ReadBraille 

 email_03Get Email Updates To receive email updates about COVID-19, enter your email address: Email Address What's this? Submit 

About CDC
Contact Us
800-232-4636

Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat


	CONTACT CDC
	

Contact Us

Call 800-232-4636

Email Us


	ABOUT CDC
	

About CDC
Jobs
Funding


	POLICIES
	

Accessibility
External Links
Privacy
Policies
No Fear Act
FOIA
OIG
Nondiscrimination
Vulnerability Disclosure Policy


	CONNECT WITH US
	

Facebook
Twitter
Instagram
LinkedIn
Coronavirus FAQs: What Veterans Need To Know | Veterans Affairs
What are VA health facilities’ guidelines on masks? 
 

When you come to a VA health facility, your health and safety are our priorities.
All facilities require masks in high-risk areas like these: 

Chemotherapy units
Dialysis units
Emergency departments and urgent care 
Post-transplant units 

Masks are also required for people who are sick with COVID-19 or other viral respiratory illnesses. 
You can choose to wear a mask at any time. If you don’t have a mask, you can ask a staff member at your VA health facility for one.
If you have more questions about mask requirements, send a secure message to your care team or contact your VA health facility.
Send a secure message to your care team
Find your nearest VA health facility

 How do I self-screen before I come to VA for care? 
 

Read this list of COVID-19 symptoms:

Fever or chills
Cough or sore throat
Shortness of breath or trouble breathing
Fatigue (feeling very tired)
Headache or muscle or body aches
New loss of taste or smell
Congestion or runny nose
Nausea, vomiting, or diarrhea

If you’ve had any of these symptoms within the past 48 hours, call first unless you need care now—even if you have an appointment. We’ll help you get any needed tests or treatment for COVID-19. Or you can go to the emergency room for COVID-19 treatment.
Note: These are not all possible COVID-19 symptoms.
Check COVID-19 symptoms on the CDC website

 How do I connect to a video telehealth appointment? 
 

Your provider will give you instructions about where to go for your video appointment. Or they’ll send you a link to join VA Video Connect.
Use VA Video Connect for your telehealth appointment
Join video appointments through our VA appointments tool

 What should I do if VA cancels my appointment due to COVID-19? 
 

We try to avoid canceling in-person appointments and elective procedures due to COVID-19 whenever possible.
Post-COVID Conditions: Information for Healthcare Providers
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Res Sq. 2021 Mar 1. doi:10.2139/ssrn.3769978
Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of Post-acute sequalae of COVID-19. Nature. 2021 Apr 22. doi:10.1038/s41586-021-03553-9
Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626-631. doi:10.1038/s41591-021-01292-y
Lund LC, Hallas J, Nielsen H, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021 May 10. doi:10.1016/S1473-3099(21)00211-5
Carfì A, Bernabei R, Landi F, et al. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020 Aug 11;324(6):603-605. doi:10.1001/jama.2020.12603
Cellai M, O’Keefe JB. Characterization of Prolonged COVID-19 Symptoms in an Outpatient Telemedicine Clinic. Open Forum Infect Dis. 2020 Oct;7(10):ofaa420. doi:10.1093/ofid/ofaa420
Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021 Feb 1;4(2):e210830.
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
Igual puede vacunarse contra el COVID-19 en forma gratuita. Obtenga más información sobre el Programa para ampliar y garantizar el acceso gratis a la vacunación de los CDC.

Vacunarse contra el COVID-19
Recursos
Para atención médica y salud públicaRecursos clínicos y profesionales para el COVID-19
Más información
Los coronavirus
Proceso de desarrollo de las vacunas: cómo se ahorró tiempo [779 KB, 1 página]

 Última actualización: 22 de sept. del 2023 Fuente: Centro Nacional de Vacunación y Enfermedades Respiratorias (NCIRD), División de Enfermedades Virales

Facebook
Twitter
LinkedIn
Sindicar